Scientists have begun testing a cure for old age

Scientists from the Buck Institute for Aging Research (California, USA) have carried out a large-scale study related to the aging process. In the course of the work, scientists found that mice that were given supplements of an endogenous metabolite lived longer than other rodents.

According to scientists, the results of their work confirm the possibility of slowing aging. The researchers said that the substance alpha-ketoglutarate (AKG) is produced in the body as a product of metabolic processes.

This molecule does not come with food, it is formed in the body only as a result of physical activity or during fasting.

Typically, this substance is added to nutritional supplements for athletes who experience significant physical activity. According to athletes, this metabolite allows them to achieve high results in sports, and bodybuilders to build muscle mass.

It should be said that this is just their opinion, since scientists have not conducted serious studies on the effect of the metabolite on the body.

Recently, however, scientists have paid attention to AKG and are interested in its effect on the human body and life expectancy. Recent studies have shown that the metabolite is able to slow down the aging process of the body.

In the next phase, the researchers intend to conduct trials on people of middle age and older.

Unlock exclusive content with Anomalien PLUS+ Get access to PREMIUM articles, special features and AD FREE experience Learn More. Follow us on Instagram, Twitter and Telegram
Default image
Jake Carter

Jake Carter is a journalist and a paranormal investigator who has been fascinated by the unexplained since he was a child.

He is not afraid to challenge the official narratives and expose the cover-ups and lies that keep us in the dark. He is always eager to share his findings and insights with the readers of anomalien.com, where he has been a regular contributor since 2013.

Newsletter Updates

Enter your email address below to subscribe to our newsletter

Leave a Reply